| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 3,780 | $40 | $143.6K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 52,380 | $1 | $52.4K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1,300 | $40 | $46.8K |
| J0897 | Injection, denosumab, 1 mg | 2,220 | $20 | $42.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 240 | $100 | $24.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 100 | $150 | $14.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 100 | $110 | $10.8K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 120 | $70 | $8.1K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1,020 | $10 | $6.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 100 | $50 | $5.5K |